Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.41B 1.24B 1.14B 1.07B 2B 133B 2.04B 13.67B 5.3B 65.5B 5.29B 5.17B 228B P/E 2026 *
27.8x
P/E 2027 * 15.1x
Enterprise Value 2.75B 2.41B 2.22B 2.08B 3.9B 259B 3.97B 26.67B 10.33B 128B 10.31B 10.09B 444B EV / Sales 2026 *
1.64x
EV / Sales 2027 * 1.49x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+1.80%
1 week+2.96%
Current month+12.84%
1 month+19.87%
3 months+89.53%
6 months+42.97%
Current year+45.73%
1 week 17.14
Extreme 17.14
18.53
1 month 14.77
Extreme 14.77
18.53
Current year 8.7
Extreme 8.7
18.53
1 year 8.7
Extreme 8.7
18.53
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2026
Director of Finance/CFO 54 27/06/2023
Chief Tech/Sci/R&D Officer - 16/02/2026
Director TitleAgeSince
Chairman 64 02/01/2012
Director/Board Member 81 31/12/1991
Director/Board Member 65 31/12/2005
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Chief Executive Officer

1,070,765 1.3758%
05-31Free

Executive/Senior Manager

92,281 0.1186%
05-08Tax

Director

-882 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+2.96%+52.49%-54.24% 1.41B
+3.04%+5.46%-32.14%-13.71% 162B
+0.49%+1.49%-6.34%-7.96% 103B
+0.87%+5.56%-1.84%+52.90% 55.83B
-2.49%-6.53%+50.99%+52.35% 54.05B
+2.44%+5.14%-11.42%-40.99% 41.71B
+4.77%+5.09% - - 31.94B
-1.58%-5.27%-18.93%-45.84% 26.49B
+1.81%+5.67%+56.80%-5.57% 24.48B
+1.66%+3.94%-12.39%-0.10% 20.52B
Average +1.28%+1.82%+8.58%-7.02% 52.19B
Weighted average by Cap. +1.44%+2.27%-6.10%-0.82%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.36B 1.27B 2.38B 158B 2.42B 16.27B 6.3B 77.95B 6.29B 6.16B 271B 1.73B 1.52B 1.4B 1.31B 2.46B 163B 2.5B 16.81B 6.51B 80.55B 6.5B 6.36B 280B
Net income 42.73M 37.54M 34.58M 32.34M 60.65M 4.03B 61.76M 415M 161M 1.99B 160M 157M 6.91B 74.56M 65.5M 60.35M 56.42M 106M 7.04B 108M 724M 280M 3.47B 280M 274M 12.05B
Net Debt 1.34B 1.18B 1.08B 1.01B 1.9B 126B 1.93B 13B 5.03B 62.25B 5.03B 4.92B 216B 1.18B 1.03B 952M 890M 1.67B 111B 1.7B 11.42B 4.42B 54.7B 4.42B 4.32B 190B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
25/06/26 US$18.10 +1.80% 848,071
24/06/26 US$17.78 +0.51% 720,164
23/06/26 US$17.69 +0.51% 860,760
22/06/26 US$17.60 +0.11% 841,317
18/06/26 US$17.58 +2.21% 2,322,863
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
18.10USD
Average target price
17.43USD
Spread / Average Target
-3.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock